UBS Group’s Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant NFYS.U Stock Holding History

UBS Group’s Portfolio NFYS.U Stock Details NFYS.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50	Closed	-$530	–	10264
2023 Q4	$530	Buy	+50	New	+$530	﹤0.01%	8609
2023 Q2	–	Sell	-10,000	Closed	-$102K	–	9945
2023 Q1	$102K	Sell	10,000 -1,308	-12%	-$13.2K	﹤0.01%	5889
2022 Q4	$117K	Sell	11,308 -432	-4%	-$4.27K	﹤0.01%	5953
2022 Q3	$115K	Buy	11,740 +1,740	+17%	+$17K	﹤0.01%	5594
2022 Q2	$97K	Hold	10,000	–	–	﹤0.01%	5462
2022 Q1	$98K	Buy	10,000 +7,058	+240%	+$69.7K	﹤0.01%	5943
2021 Q4	$29K	Buy	+2,942	New	+$29K	﹤0.01%	7435

Other funds holding NFYS.U

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's NFYS.U Position: Q1 2024 in Review

UBS Group sold out of Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (NFYS.U) in Q1 2024, closing a stake of 50 shares — an estimated $530 sold.

UBS Group first reported a position in NFYS.U in Q4 2021 and held it in 7 quarters. The position peaked at $117K in Q4 2022. 1 fund tracked by Wall St. Rank holds NFYS.U as of Q1 2024.

UBS Group reported no remaining Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q1 2024 after selling out during the quarter.
UBS Group sold 50 Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q1 2024, an estimated $530.
UBS Group first reported a position in Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q4 2021 and held it in 7 quarters.
UBS Group's Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $117K in Q4 2022.
1 fund tracked by Wall St. Rank held Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.